title: Do we need angiotensin II antagonists to treat hypertensive patients?
authors.affiliation: Hôpital Broussais, Centre de Médecine Préventive Cardiovasculaire, Paris, France.
authors.forename: J
authors.initials: J
authors.lastname: Ménard
authors.forename: G
authors.initials: G
authors.lastname: Chatellier
authors.forename: M
authors.initials: M
authors.lastname: Azizi
mesh_terms: D000804:Angiotensin II / Q000037:antagonists & inhibitors*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001562:Benzimidazoles / Q000627:therapeutic use; D001713:Biphenyl Compounds / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D013777:Tetrazoles
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D013777:Tetrazoles; D000804:Angiotensin II; C077793:candesartan cilexetil